connected drug delivery   Connected Drug Delivery • Published October 2016  •  Catalog no. FDJ583K  •  Price US $3,850


For self-administration, adherence with drug therapy and disease management protocols has become a primary concern within the healthcare and pharmaceutical industries. For chronic conditions adherence has a direct effect on the patient’s quality-of-life. Connected devices – drug delivery devices that are designed to address the patient adherence issue by reminding and recording data about patient dosing activity and making it available to HCPs – are gaining interest among industry and managed care participants. Efforts to enhance adherence have a non-negligible effect on drug formulations and delivery decisions, and are a significant factor in the prescribing decisions of most physicians. The connected device ecosystem includes OEM device suppliers, drug developers, human factors consultants and aftermarket third-party devices.

Bar_Graph  Connected Device Report Brochure (Download PDF)

Blue document  Connected Device Report Order Form (Download PDF)


Connected Drug Delivery – What You Will Learn

• What drug delivery devices incorporate connectivity technology, how do they work and what new capabilities do they offer to patients and their HCPs?
• What benefits do connected drug delivery devices provide to patients in the area of improved adherence? Patient safety and reported outcomes? HCP/patient communication?
• What therapeutic areas are the current focus of connected devices?
• Who are the companies behind the push to connected delivery devices? What are their development activities and corporate alliances and affiliations?
• What is the importance of pharma-device alliances and design partnerships on connected drug delivery device commercialization and market access?
• What does the current market for connected drug delivery devices look like? What will it look like in 2020?
• What are the key market drivers for the growth of connected drug delivery devices?


Connected Drug Delivery – Summary of Contents

Executive Summary

Connected Devices – The Opportunity

Drug Development Trends
The Rapid Rise of Prefilled Devices
Factors Driving Drug Self-Administration
Therapeutic Demand Drivers
The Impact of Developing Economies

Wireless Connectivity Technologies

Bluetooth
Cellular
Near Field Communications
Emerging Technologies

Wirelessly Connected Device Analysis

Inhalation
Integrated Connected Devices
Third Party/Aftermarket Connectivity Devices
Injection
Connected Handheld Injection Devices
Connected Wearable Injection Devices
Vendor-specific Connectivity Platforms
Third Party Connectivity Devices
Solid Dosage Forms
Transdermal Systems

Near-term Markets and Applications

Addiction
Anaphylaxis
Autoimmune Diseases
Cardiovascular
Diabetes
Hormone Replacement
Neurology
Upper Respiratory Diseases

Market Factors

Regulatory Requirements
Data Security
Patient Acceptance and Training

Company Profiles

Comments or questions?

* indicates required field

 


Useful Links:

Connected Devices